Cargando…

Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.

Detalles Bibliográficos
Autores principales: Oster, W. F., Firminger, H. I., Morrison, D. M.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1971
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592972/
https://www.ncbi.nlm.nih.gov/pubmed/4325376
_version_ 1782161598367924224
author Oster, W. F.
Firminger, H. I.
Morrison, D. M.
author_facet Oster, W. F.
Firminger, H. I.
Morrison, D. M.
author_sort Oster, W. F.
collection PubMed
description
format Text
id pubmed-2592972
institution National Center for Biotechnology Information
language English
publishDate 1971
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-25929722008-12-04 Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen. Oster, W. F. Firminger, H. I. Morrison, D. M. Yale J Biol Med Research Article Yale Journal of Biology and Medicine 1971 /pmc/articles/PMC2592972/ /pubmed/4325376 Text en
spellingShingle Research Article
Oster, W. F.
Firminger, H. I.
Morrison, D. M.
Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title_full Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title_fullStr Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title_full_unstemmed Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title_short Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
title_sort inhibition of n-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592972/
https://www.ncbi.nlm.nih.gov/pubmed/4325376
work_keys_str_mv AT osterwf inhibitionofn2fluorenyldiacetamideinducedhepaticcarcinogenesisinratsbychloramphenicoladoserelatedphenomenonwithreducedproteinbindingofcarcinogen
AT firmingerhi inhibitionofn2fluorenyldiacetamideinducedhepaticcarcinogenesisinratsbychloramphenicoladoserelatedphenomenonwithreducedproteinbindingofcarcinogen
AT morrisondm inhibitionofn2fluorenyldiacetamideinducedhepaticcarcinogenesisinratsbychloramphenicoladoserelatedphenomenonwithreducedproteinbindingofcarcinogen